Post Categories
QPS Missouri Collaborates with Local Agency to Bring Birthday Celebrations to Underserved Children
August 8, 2019
Wish I May is a volunteer-run 501(c)(3) non-profit organization in the Springfield, Missouri, community striving to make a difference one child and one birthday at…
Interested in Plaque-Associated Inflammation?
July 19, 2019
Are you interested in exploring plaque-associated inflammation? QPS Neuropharmacology, a division of QPS (a leading CRO for drug development), is your partner for the visualization…
Available Now! Tiotropium Assay for Generic and 505(b)(2) Studies.
July 12, 2019
While the wave of small molecule drug therapies going off patent has peaked, there are still a number that will be losing patent protection…
Impact of Biomarkers on Current Parkinson’s Disease Treatment Research
July 8, 2019
About a century ago, Otto Loewi discovered in his laboratories in Graz, Austria, that nerve impulses are transmitted by chemical messengers like acetylcholine. Since…
The 6 C’s of Innovation in Customer Excellence
July 1, 2019
Although customer service is a critical component of the global economy, there is surprisingly little innovation in the field compared to the ingenuity in…
QPS Celebrating Sustained Growth in Asia
June 24, 2019
Did you know that 23.6 percent of the world’s pharmaceutical companies are now located in Asia? That’s up from 20.5 percent in 2018 –…
Conference Report: EAACI Annual Conference in Lisbon, Portugal on June 1 – 5, 2019
June 17, 2019
Professor Zuzana Diamant, MD PhD, Executive Medical and Scientific Director of Respiratory & Allergy at QPS Netherlands, and EAACI Asthma Section Chair 2017-2019, lectured…
Power Women in Business Development at QPS Netherlands
June 13, 2019
Two power women currently ‘man’ the Business Development (BD) department at QPS Netherlands, in close collaboration with the Head of BD, Edwin van Vulpen,…
Inflammatory Disease Models and Biomarkers
June 10, 2019
Trained and supervised by internationally recognized experts, we have acquired skills in a variety of inflammatory disease models at QPS. Such models can be…
Accelerating Pharmaceutical Breakthroughs for CNS Disorders
June 5, 2019
Although we’ve made great progress in our understanding of the central nervous system (CNS) and the disorders that affect it, CNS drug development continues…
Skin Biopsy: A Complex Model Exploring Gene Expression
May 9, 2019
The heterogeneous presentation of clinical cases and the complex requirements by health authorities and care management contribute to making the development of innovative treatment…
QPS: Young at Heart
May 9, 2019
At QPS, we work with a team of Research Physicians, who are all young professionals pursuing a career in Drug Development and/or Clinical Pharmacology….
Reporting Live From the Brain — Tiny Microscope Tracks Activity in Moving Mice
December 5, 2022
Human brains consist of around 86 billion neurons that connect and communicate with each other, forming an intricate network. Understanding how the human brain…
From Cultural Rite to Clinical Trial — Examining the Therapeutic Potential of Mescaline
November 28, 2022
Psychedelics are having a moment, as researchers, startups, and regulators are recognizing the potential of these previously stigmatized compounds for treating mental health disorders….
Researchers Find New Hybrid Virus in Lung Cells
November 21, 2022
Winter is approaching, and with it, flu season. Cases of both influenza (flu) and the respiratory syncytial virus (RSV) tend to experience their peak…
New Anti-Amyloid Drug Offers Cognitive Benefit for Patients with AD
November 16, 2022
A recent Phase III clinical trial found that lecanemab reduces cognitive decline in patients with early Alzheimer’s disease (AD). The findings indicate that participants…
Can UV Light Replace Masks in the Fight Against COVID-19?
November 9, 2022
As the world continues to grapple with the ongoing COVID-19 pandemic, scientists continue to investigate a variety of potential treatments and prevention methods. Previous…
Cancer Trials Ask, What’s the Gut Got to Do With It?
November 7, 2022
There are ten times more bacterial cells in your body than human cells. They live in our noses, in our guts, and everywhere in…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
